Low-dose radiotherapy combined with immune checkpoint inhibitors in advanced malignancies: a real-world exploratory study
Translational Cancer Research · 2026-06 · 15 (6) · 504-504
DOI: 10.21037/tcr-2026-0709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Cancer Research, 2026-06. Verfasst von Kai Xin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Oncology, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Oncology, Nanjing Drum Tower Hospital, The Clinical College of Nanjing Medical University, Nanjing, China.
Zitieren
APA
Xin, K., Deng, L., Ding, M., Feng, M., Wu, X., & Zhu, L. (2026). Low-dose radiotherapy combined with immune checkpoint inhibitors in advanced malignancies: a real-world exploratory study. Translational Cancer Research, 15(6), 504-504. https://doi.org/10.21037/tcr-2026-0709
Vancouver
Xin K, Deng L, Ding M, Feng M, Wu X, Zhu L. Low-dose radiotherapy combined with immune checkpoint inhibitors in advanced malignancies: a real-world exploratory study. Translational Cancer Research. 2026;15(6):504-504. doi:10.21037/tcr-2026-0709
BibTeX
@article{Xin2026,
author = {Xin, Kai and Deng, Liping and Ding, Meiqing and Feng, Mengmeng and Wu, Xiahui and Zhu, Lijing},
title = {Low-dose radiotherapy combined with immune checkpoint inhibitors in advanced malignancies: a real-world exploratory study},
journal = {Translational Cancer Research},
year = {2026},
volume = {15},
number = {6},
pages = {504--504},
doi = {10.21037/tcr-2026-0709}
}
EUVIMED